CochLear (OTCMKTS:CHEOY) Sets New 52-Week Low – Should You Sell?

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report)’s share price reached a new 52-week low on Monday . The company traded as low as $61.80 and last traded at $62.51, with a volume of 1638 shares. The stock had previously closed at $62.30.

Analyst Ratings Changes

Separately, Royal Bank Of Canada upgraded CochLear from a “hold” rating to a “moderate buy” rating in a report on Monday, January 19th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.

Read Our Latest Report on CochLear

CochLear Stock Up 1.2%

The business has a 50 day moving average of $83.45 and a 200 day moving average of $89.64.

About CochLear

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Featured Articles

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.